Publications:40
Satish Vishram Rojekar, PhD
Satish Rojekar (Preferred Name)
About Me
Satish Rojekar, PhD., M.Pharm. is an Assistant Professor and Director of the Drug Development and Nanomedicine Core at the Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai. With a Ph.D. in Pharmaceutics, his research focuses on biotherapeutics, nanomedicine, microneedle drug delivery, and pharmaceutical technology to improve treatments for chronic disorders like obesity, osteoporosis, Alzheimer's, and HIV.
He has authored over 42 peer-reviewed publications, holds three patents, and has contributed 10 book chapters. Dr. Rojekar serves as an editor for several prestigious journals, including PLOS ONE, Current Drug Delivery, Scientifica, Frontier in Pharmacology, and Current Pharmaceutical Biotechnology. He is also a member of numerous scientific societies, including AAPS, CRS, ASBMR, the Endocrine Society, and the British Society of Nanomedicine. His work continues to drive innovation in drug delivery technologies, establishing him as a scientific leader, mentor, and collaborator within the global pharmaceutical research community.
Language
Position
Research Topics
Adipose, Aging, Alzheimer's Disease, Antibody Development, Antivirals, Biomechanics/Bioengineering, Biomedical Sciences, Biophysics, Blood-Brain Barrier, Cellular Immunity, Dermatology, Drug Design and Discovery, Drug Resistance, Endocrinology, Gene Therapy, HIV/AIDS, Immunology, Infectious Disease, Intracellular Transport, Mass Spectrometry, Nanotechnology, Obesity, Osteoporosis, Oxidative Stress, Personalized Medicine, Pharmacology, Positron Emission Tomography, Technology & Innovation, Translational Research, Vaccine Development, Viruses and Virology
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Immunology [IMM], Neuroscience [NEU]
About Me
Satish Rojekar, PhD., M.Pharm. is an Assistant Professor and Director of the Drug Development and Nanomedicine Core at the Center for Translational Medicine and Pharmacology, Icahn School of Medicine at Mount Sinai. With a Ph.D. in Pharmaceutics, his research focuses on biotherapeutics, nanomedicine, microneedle drug delivery, and pharmaceutical technology to improve treatments for chronic disorders like obesity, osteoporosis, Alzheimer's, and HIV.
He has authored over 42 peer-reviewed publications, holds three patents, and has contributed 10 book chapters. Dr. Rojekar serves as an editor for several prestigious journals, including PLOS ONE, Current Drug Delivery, Scientifica, Frontier in Pharmacology, and Current Pharmaceutical Biotechnology. He is also a member of numerous scientific societies, including AAPS, CRS, ASBMR, the Endocrine Society, and the British Society of Nanomedicine. His work continues to drive innovation in drug delivery technologies, establishing him as a scientific leader, mentor, and collaborator within the global pharmaceutical research community.
Language
Position
Research Topics
Adipose, Aging, Alzheimer's Disease, Antibody Development, Antivirals, Biomechanics/Bioengineering, Biomedical Sciences, Biophysics, Blood-Brain Barrier, Cellular Immunity, Dermatology, Drug Design and Discovery, Drug Resistance, Endocrinology, Gene Therapy, HIV/AIDS, Immunology, Infectious Disease, Intracellular Transport, Mass Spectrometry, Nanotechnology, Obesity, Osteoporosis, Oxidative Stress, Personalized Medicine, Pharmacology, Positron Emission Tomography, Technology & Innovation, Translational Research, Vaccine Development, Viruses and Virology
Multi-Disciplinary Training Areas
Disease Mechanisms and Therapeutics (DMT), Immunology [IMM], Neuroscience [NEU]